Credit: McMaster University
Gerry Wright, professor of Biochemistry and Biomedical studies at McMaster, says his lab’s recent discovery is significant because the antibiotic apramycin is currently in clinical trials and, should it pass through, having a thorough understanding of how bacteria might resist the drug will be crucial to extending its utility.